Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Read
Is Merck A Good Stock To Buy?
Article By:
Dividend Power
Thursday, January 13, 2022 8:59 AM EST
MRK is a ~$200B market cap drug manufacturer. It is engaged in research to prevent and treat diseases that threaten people and animals such as cancer, infectious diseases (eg. HIV and Ebola), and emerging animal diseases.
In this article: MRK
E Market Briefing For Thursday, Dec. 23
Article By:
Gene Inger
Thursday, December 23, 2021 3:05 AM EST
'Fortune favors the brave' it is said; it's partially so in this market, where we certainly got the ignition Tuesday of the seasonal rebound we looked for and more on Wednesday.
E Wednesday Global Investing Report
Article By:
Vivian Lewis
Wednesday, December 8, 2021 7:56 PM EST
Between the Amazon Cloud issues and the clouds gathering over the Ukraine border, it's getting harder to tell exactly what's happening to markets. Here are some insights into the international companies in our portfolio.
In this article: CVE, GSK, MRK, NVO, PFE, VE, RHHBY, SSNLF, SZEVF, TMRAF, MELI, TSEM, MRNA, TBPH, KL, BNTX
7 Monster Stock Market Predictions – The Week Of Oct. 4 Edition
Article By:
Michael J. Kramer
Sunday, October 3, 2021 3:13 AM EST
Stocks rallied to finish the week of October 1, with the S&P 500 rising by 1.15%. The advance on Friday coincidences with a volatility crush, with the VIX, fell by 8.6% to finish at 21.1 on Friday.
OncoSec Raising Its Profile In Fight Against Cancer
I appreciate a promising investment that also helps people. Bullish on $ONCS and $MRK.
OncoSec Raising Its Profile In Fight Against Cancer
Thanks for this info, @[Terry Chrisomalis](user:5023). Is there any sort of official partnership or cooperation between #OncoSecMedical and #Merck to use ImmunoPulse IL-12 technology in conjunction with #Keytruda? $ONCS $MRK
OncoSec Raising Its Profile In Fight Against Cancer
Very impressed with the #OncosSec trial results. $ONCS $MRK $BMY